<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03114774</url>
  </required_header>
  <id_info>
    <org_study_id>71306642-050.01.04-21/29</org_study_id>
    <nct_id>NCT03114774</nct_id>
  </id_info>
  <brief_title>Effectivity of Bispectral Index Monitoring in Cases of Endoscopic Retrograde Cholangiopancreatography</brief_title>
  <official_title>Evaluation of Effectivity of Bispectral Index Monitoring in Cases of Endoscopic Retrograde Cholangiopancreatography Received Sedoanalgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Medeniyet University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Medeniyet University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The bispectral index (BIS) monitoring is an EEG-based method that uses electroencephalogram
      analysis and a complex algorithm to generate a numerical scoring 0-100 (0 flat line EEG, 100,
      wide awake) BIS monitoring allows noninvasive, objective measurement of level of
      consciousness of a sedated patient. A limited number of studies have used measurements of BIS
      monitoring to assist endoscopic sedation.There are studies using BIS monitoring to make
      sedation easy for ERCP procedures. However, the studies evaluating use of BIS for
      gastrointestinal endoscopy show inconsistent results.

      The objective of this study is to evaluate effects of sedation on the dosage of propofol by
      monitoring with BIS values, hemodynamics, recovery parameters, respiratory functions and
      endoscopist satisfaction based on the hypothesis that the investigators would reduce the risk
      for respiratory depression using minimal doses of propofol in order to achieve the desired
      level of sedation with BIS monitoring.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 15, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total dosage of propofol</measure>
    <time_frame>1-3 hours</time_frame>
    <description>initial dose 1 mg.kg-1 of propofol, maintenance dose: infusion of 4 mg/kg/h . In case of insufficient sedation, additional dose of 0.1 mg/kg propofol (IV) by monitoring with BIS values 65-75 during procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The heart rate (HR)(n/dk)</measure>
    <time_frame>1-3 hours</time_frame>
    <description>During procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mean systolic-diastolic blood pressure(mmHg)</measure>
    <time_frame>1-3 hours</time_frame>
    <description>during procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>peripheral oxygen saturation (%)</measure>
    <time_frame>1-3 hours</time_frame>
    <description>During procedure</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sedoanalgesia</condition>
  <arm_group>
    <arm_group_label>grup 1</arm_group_label>
    <description>Ramsay Sedation Scale (RSS) Score monitoring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grup 2</arm_group_label>
    <description>The bispectral index (BIS) monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The bispectral index (BIS) monitoring</intervention_name>
    <arm_group_label>Grup 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Ramsay Sedation Scale (RSS) Score monitoring</intervention_name>
    <arm_group_label>grup 1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients in ASA 1-2 category scheduled for sedation and ERCP
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 20-75 years old

          2. ASA 1-2

        Exclusion Criteria:

          1. Emergency Operation

          2. Those who had symptoms of neurological disease (TÄ°A, syncope, dementia, etc.)

          3. Patients that are allergic to drugs considered to use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2017</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2017</study_first_posted>
  <last_update_submitted>April 10, 2017</last_update_submitted>
  <last_update_submitted_qc>April 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Medeniyet University</investigator_affiliation>
    <investigator_full_name>Ferda Yilmaz Inal</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

